Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Achieve Life Sciences, Inc. - Common Shares (NQ:ACHV)

5.260 -0.340 (-6.07%)
Streaming Delayed Price Updated: 1:36 PM EST, Jan 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Achieve Life Sciences, Inc. - Common Shares

< Previous 1 2 3 4 5 Next >
News headline image
Can't Kick the Bud? Achieve's Cytisinicline Proves Promising in Phase 3 Smoking Cessation Trial ↗
Achieve Life Sciences Inc (NASDAQ: ACHV) announced topline results from the second  
Via Benzinga
News headline image
BJ's Wholesale, Kingsoft Cloud, Zoom Video And Other Big Stocks Moving Lower On Tuesday ↗
U.S. stocks traded mixed, with the Nasdaq Composite dropping around 30 points on Tuesday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
Recap: Achieve Life Sciences Q1 Earnings ↗
 
Via Benzinga
Achieve Life Sciences Inc. (NASDAQ: ACHV) Climbs to New 52-Week High
Via Investor Brand Network
News headline image
Want To Quit Smoking? Achieve Life Sciences Reports Successful E-Cigarette Cessation Benefit With Cytisinicline Treatment ↗
 
Via Benzinga
News headline image
Top 5 Health Care Stocks That May Collapse ↗
The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. 
Via Benzinga
News headline image
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
Topline Data Expected in 2Q 2023 
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences's Earnings: A Preview ↗
 
Via Benzinga
News headline image
Achieve Life Sciences Announces Last Subject Last Visit Completed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
Topline Data Expected in 2Q 2023 
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Presentation of the Phase 3 ORCA-2 Trial of Cytisinicline at Society for Research on Nicotine and Tobacco (SRNT) Annual Meeting
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Refresh to Board of Directors
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Last Subject Dosed in Phase 2 ORCA-V1 Trial of Cytisinicline for e-Cigarette Cessation
Topline Data Expected in 2Q 2023 
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Achieve Life Sciences Announces Granting of New Hire Inducement Award
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences to Announce Fourth Quarter and Year-End 2022 Financial Results and Host Conference Call and Webcast on March 16, 2023
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Last Subject Dosed in Phase 3 ORCA-3 Trial of Cytisinicline for Smoking Cessation
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Life Sciences Announces Patent Granted by USPTO for New Cytisinicline Formulation
From Achieve Life Sciences
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Why ObsEva Shares Are Trading Higher By Over 70%; Here Are 21 Stocks Moving Premarket ↗
Gainers ObsEva SA (NASDAQ: OBSV) shares rose 71.9% to $0.2848 in pre-market trading after the company reported the sale of Ebopiprant license agreement to XOMA for up to $113 million. 
Via Benzinga
News headline image
Achieve Life Sciences Announces Private Placement of $18.9 Million
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Achieve Announces Early Completion of Target Enrollment in Cytisinicline e-Cigarette Cessation Trial
Phase 2 ORCA-V1 Data Expected in 1H2023 
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
  During Monday's session, 96 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Achieve Life Sciences to Announce Third Quarter Financial Results and Host Conference Call and Webcast on November 14, 2022
From Achieve Life Sciences
Via GlobeNewswire
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  During Tuesday's session, 78 companies made new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  During Friday, 125 stocks hit new 52-week lows. 
Via Benzinga
News headline image
121 Stocks That Hit Their 52-Week Low ↗
New Equities that Broke Through 52-Week Lows Friday Morning During Friday's morning session, 121 stocks hit new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Friday ↗
  On Friday, 39 companies reached new 52-week lows. 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Monday ↗
During Monday's session, 77 companies made new 52-week lows. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.